Helicobacter pylori and oesophageal cancer - Not always protective

Gut

Volumn 56, Issue 4, 2007, Pages 457-459

  McColl, Kenneth E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; CANCER RISK; DISEASE ASSOCIATION; DUODENUM ULCER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; NOTE; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH ULCER;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GASTRITIS, ATROPHIC; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 34147207620     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.111385     Document Type: Note

References (29)

1. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
2. Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastrooesophageal reflux disease. Aliment Pharmacol Ther 2003;18:279-89.
3. Raghunath A, Pali A, Hungin S, et al. Prevalence of Helicobacter pylori in patients with gastrooesophageal reflux disease: systematic review. BMJ 2003;326:737-9.
4. Wu JCY, Sung JJY, Chan FKL, et al. Helicobacter pylori infection is associated with milder gastrooesophageal reflux disease. Aliment Pharmacol Ther 2000;14:427-32.
5. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's oesophagus. Am J Gastroenterol 1992;87:1598-1600.
6. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of CagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
7. Siman H, Held M, Engstrand I, et al. Helicobacter pylori CagA seropositivity reduces the risk of developing adenocarcinoma and squamous cell carcinoma in the oesophagus. Gut. 2002;51: A65 (abstract), (suppl. 11).
8. de Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and subsequent adenocarcinoma of the oesophagus. Gastroenterology 2003;125:605-7.
9. Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia and Barrett's adenocarcinoma. Am J Gastroenterol 2000;95:387-94.
10. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Nat Cancer Inst 2004;96(5):387-396.
11. de Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. JID 2005;191:761-7.
12. Wu JCY, Sung JJY, Ng KWE, et al. Prevalence and distribution or Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999;94(7):1790-4.
13. Laine I, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002;97:2992-7.
14. Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobader pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003;18:279-89.
15. Moayyedi P, Bardhan C, Young L, et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120-6.
16. Delaney B, Moayyedi P. Eradicating H pylori does not increase symptoms of gastro-oesophageal reflux disease. BMJ 2004;328:1388-9.
17. Koike T, Ohara S, Sekine H, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 2001;15:813-20.
18. Wu YCY, Chan FKL, Ching JYL, et al. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004;53:174-9.
19. McColl KEL, El-mar E, Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 2000;29:687-703.
20. Grossman MI, Kirsner JB, Gillespie IE. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 1963;45:14-26.
21. Frizis HI, Whitfield PF, Hobsley M. Maximal gastric secretion and duodenogastric reflux in patients with gastric or duodenal ulcer and in control subjects. Br J Surg 1987;74:106-9.
22. Grossman MI, Kirsner JB, Gillespie IE. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 1963;45:14-26.
23. Stadelmann O, Elster K, Stolte M, et al. The peptic gastric ulcer-histoporgraphic and functional investigations. Scand J Gastroent 1971;6:613-23.
24. Wormsley KG, Grossman MI. Maximal histalog test in control subjects and patients with peptic ulcer. Gut 1965;6:427-35.
25. Baron JH. An assessment of the augmented histamine test in the diagnosis of peptic ulcer. Gut 1963;4:243-53.
26. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid secretion. Gastroenterology 1997;113:15-24.
27. Bahmanyar G, Zendendel K, Nyrén O, et al. Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers. Gut 2007;56:464-8.
28. Naylor GM, Gotoda T, Dixon M, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006;55:1545-52.
29. Iijima K, Koike T, Sedine H, et al. Gastric atrophy may be associated with the development of squamous cell carcinoma of the esophagus in Japan. Gastroenterology. 2006;130: 4, (Suppl 2):M2090.